Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
letter
. 1989 Aug;28(2):208–209. doi: 10.1111/j.1365-2125.1989.tb05421.x

Drug treatment of intermittent claudication.

K H Labs
PMCID: PMC1379910  PMID: 2775629

Full text

PDF
208

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Accetto B. Beneficial hemorheologic therapy of chronic peripheral arterial disorders with pentoxifylline: results of double-blind study versus vasodilator-nylidrin. Am Heart J. 1982 May;103(5):864–869. doi: 10.1016/0002-8703(82)90401-x. [DOI] [PubMed] [Google Scholar]
  2. Cameron H. A., Waller P. C., Ramsay L. E. Drug treatment of intermittent claudication: a critical analysis of the methods and findings of published clinical trials, 1965-1985. Br J Clin Pharmacol. 1988 Nov;26(5):569–576. doi: 10.1111/j.1365-2125.1988.tb05297.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Gillings D., Koch G., Reich T., Stager W. J. Another look at the pentoxifylline efficacy data for intermittent claudication. J Clin Pharmacol. 1987 Aug;27(8):601–609. doi: 10.1002/j.1552-4604.1987.tb03072.x. [DOI] [PubMed] [Google Scholar]
  4. Porter J. M., Cutler B. S., Lee B. Y., Reich T., Reichle F. A., Scogin J. T., Strandness D. E. Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients. Am Heart J. 1982 Jul;104(1):66–72. doi: 10.1016/0002-8703(82)90642-1. [DOI] [PubMed] [Google Scholar]
  5. Rössner M., Müller R. On the assessment of the efficacy of pentoxifylline (Trental). J Med. 1987;18(1):1–15. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES